The Effect of Acupressure on Multiple Sclerosis Patients (NCT07558252) | Clinical Trial Compass
CompletedNot Applicable
The Effect of Acupressure on Multiple Sclerosis Patients
Turkey (Türkiye)90 participantsStarted 2025-03-01
Plain-language summary
There are studies in the literature evaluating the effects of acupressure application in MS patients. In a study; it was shown that acupressure application reduced pain and fatigue. In a study; acupressure was found to reduce fatigue and depression scores. In a study; acupressure was found to improve the patient's physical and cognitive functions and quality of life. In a study; acupressure was found to have positive effects on reducing fatigue in MS patients. In a study acupressure application was found to have significant effects in reducing fatigue. There are no studies evaluating the combined effects of acupressure on fatigue, pain, sleep quality, and quality of life parameters in MS patients. This study is planned to determine the effects of acupressure on fatigue, pain, sleep quality, and quality of life in MS patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* At least 6 months of confirmed MS diagnosis
* With RRMS
* Aged 18 years or older
* With a pain score of VAS≥3
* Not having used pain medication in the last 8 hours prior to the acupressure session
* With a Fatigue Severity Scale score of 4 or higher
* Without a diagnosis of cancer
* Without diabetes
* No neurological disease other than MS
* Not receiving any other complementary treatment
* Non-smoker
* Literate and able to communicate
* No deformity or lesion in the areas where acupressure will be applied
* No mental problems that could prevent cooperation with the acupressure application
* Not taking sedative medication
* With stable vital signs
* Without heart disease
* Not pregnant
* Residing in Şanlıurfa
* Patients who are willing to participate in the study
Exclusion Criteria:
* Patients who did not attend at least 4 sessions
* Patients who wish to withdraw from the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fatigue Severity Scale (FSS)
Timeframe: Baseline, at the end of the 3rd week, and at the end of the 6th week.